Cleveland-Cliffs
CLF
$12.50
-2.04%
Cleveland-Cliffs Inc. is a vertically integrated North American flat-rolled steel producer and iron ore pellet manufacturer, operating blast furnaces, direct reduced iron facilities, and downstream stamping, tooling, and tubular finishing assets that supply the automotive, appliance, construction, and industrial markets, with the Steelmaking segment generating roughly $4.76 billion of a recent quarter's $4.92 billion in revenue. As the largest flat-rolled steel producer in North America and a major supplier to the Detroit automakers, Cliffs occupies a scale-driven, high-fixed-cost position in a cyclical, capital-intensive industry where domestic protectionism is a core part of its competitive identity. The current investor narrative is a high-stakes turnaround bet: after a brutal stretch of quarterly losses, management has pointed to a 2026 recovery, and headlines such as the July 23 surge on "robust steel demand and pricing" and doubled EBITDA guidance, plus the August 21 pop tied to a $1 billion investment in its flagship plant and potential tariff relief, have reignited debate over whether tariff-supported pricing can finally translate into durable profitability. Against that optimism sits a skeptical analyst community and a still-negative earnings base, making CLF a battleground stock between cyclical-recovery bulls and those who see structurally impaired margins.…
CLF
Cleveland-Cliffs
$12.50
Related headlines
Investment Opinion: Should I buy CLF Today?
The synthesized recommendation is Hold, with a clear thesis that Cliffs is a legitimate cyclical recovery story whose improving EBITDA and revenue trends are not yet sufficient to offset negative gross margins, heavy cash burn, and a balance sheet that requires external funding. The analyst consensus reinforces this stance: 10 analysts rate the stock a hold with a recommendation mean of 2.92, and the average target price of $12.20 implies just +1.2% upside from the current $12.06, essentially no expected return. Until the company demonstrates sustainable positive gross margins, the risk/reward does not justify a Buy rating despite the deep historical valuation discount.
The supporting evidence is mixed but leans cautious. On the positive side, Q1 2026 revenue grew 6.33% year-over-year to $4.922 billion, EBITDA swung from -$208 million to +$100 million, and the price-to-sales ratio of 0.351x sits far below the 2.82x seen in Q1 2022 and 2.02x in Q4 2023. However, the negative gross margin of -1.67%, trailing free cash flow of -$997 million, debt-to-equity of 1.336, and ROE of -24.17% show that the business is not yet self-sustaining. The forward PE of 20.21x on estimated EPS of $0.894 means the market is already pricing a full recovery, so the stock is not statistically cheap on earnings — it is only cheap on sales and book value, which are inferior metrics for a company with impaired profitability.
The biggest risks that could invalidate even a Hold rating are a failure of steel pricing to hold, another equity raise that dilutes shareholders, and a tariff policy reversal that removes the domestic pricing umbrella. This Hold would upgrade to Buy if gross margins turn positive for two consecutive quarters and free cash flow inflects toward breakeven, or if the stock pulls back toward the $10.00 analyst low target while the recovery remains on track. It would downgrade to Sell if Q2 or Q3 2026 revenue declines sequentially, if gross margins fall back below -5%, or if the company announces another large equity offering. Relative to its own history, CLF is undervalued on sales and book value, but relative to its current earnings power and peer profitability, it is fairly valued at best — the discount is compensation for genuine financial risk, not a free lunch.
Sign up to view all
CLF 12-Month Price Forecast
The forward-looking view is genuinely balanced: the EBITDA inflection and 6.33% revenue growth are real positives, but negative gross margins and -$997 million trailing free cash flow mean the recovery is not yet self-sustaining. The market is pricing a full recovery through the 20.21x forward PE on $0.894 estimated EPS, leaving little room for disappointment, while the 0.351x PS ratio reflects impaired economics rather than a mispricing. With a 2.11 beta and 5.02 short ratio, the stock is a high-variance catalyst-driven name where the consensus target offers no margin of safety. I would upgrade to bullish if gross margins turn positive for two consecutive quarters and free cash flow approaches breakeven, and downgrade to bearish if revenue declines sequentially or another equity raise is announced. Until then, the risk/reward is symmetric at best, and the 25/50/25 probability distribution reflects that uncertainty.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cleveland-Cliffs's 12-month outlook, with a consensus price target around $12.30 and implied upside of -1.6% versus the current price.
Average Target
$12.30
0 analysts
Implied Upside
-1.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$10 - $15
Analyst target range
Coverage is moderate with 10 analysts, and the consensus is decidedly neutral: the recommendation is "hold" with a recommendation mean of 2.92 (where 3.0 is a hold), and the average target price of $12.20 implies just +1.2% upside from the current $12.06 — essentially no expected return. The consensus leans neutral-to-cautious rather than bullish, and the institutional ratings flow reinforces this: Morgan Stanley downgraded from Overweight to Equal Weight on June 22, 2026, while GLJ Research upgraded from Sell to Hold on June 9, 2026, and the bulk of recent actions (Wells Fargo, BofA, Citigroup, JP Morgan) are Neutral/Equal Weight reiterations. The pattern of a notable downgrade offset by a reluctant upgrade, with most firms parked at neutral, signals an analyst community that sees the recovery potential but is unwilling to underwrite it until margins turn sustainably positive. The target range spans $10.00 to $15.00, a spread of 50% from low to high that signals meaningful uncertainty about the recovery's magnitude. The $15.00 high target implies roughly +24% upside and would require the company to deliver on its doubled EBITDA guidance, realize tariff-supported pricing, and see the $1 billion flagship plant investment translate into margin expansion — essentially a full cyclical upcycle with multiple expansion. The $10.00 low target implies about -17% downside and prices in continued margin compression, failure of steel pricing to hold, and the risk that the recovery narrative fades, leaving the company burning cash with a stretched balance sheet. The wide spread, combined with the 2.11 beta and 5.02 short ratio, means position sizing and risk management are paramount — this is a high-variance, catalyst-driven name where the consensus offers no margin of safety and the outcome depends almost entirely on whether steel pricing and tariff policy cooperate.
Bulls vs Bears: CLF Investment Factors
The bear case currently has stronger evidence because the company is still posting negative gross margins (-1.67% in Q1 2026), burning nearly $1 billion in trailing free cash flow, and carrying a balance sheet with negative interest coverage. The bull case rests on a genuine EBITDA inflection from -$208 million to +$100 million, 6.33% revenue growth, and a historically cheap 0.351x PS ratio that could re-rate if the recovery delivers. The single most important tension is whether tariff-supported steel pricing can lift gross margins sustainably above zero — if it does, the forward PE of 20.21x on $0.894 EPS becomes achievable and the stock re-rates; if it does not, the company faces continued cash burn and potential dilution. With analysts clustered at a $12.20 average target (+1.2% upside) and a 2.11 beta, the market is pricing a binary outcome rather than a gradual recovery. Until gross margins turn positive for at least two consecutive quarters, the risk/reward remains skewed to the downside despite the improving trend.
Bullish
- EBITDA inflected positive: Adjusted EBITDA swung from -$208 million in Q1 2025 to +$100 million in Q1 2026, a $308 million improvement that shows the company is moving toward cash breakeven. Management doubled its EBITDA guidance on July 23, 2026, and the stock jumped 15.9% that day (from $9.45 to $10.96), confirming the market rewards tangible profitability progress.
- Revenue growth resumed: Q1 2026 revenue of $4.922 billion rose 6.33% year-over-year versus $4.629 billion in Q1 2025, and the sequential path from Q4 2025's $4.313 billion trough shows a clear rebound. The Steelmaking segment generated $4.757 billion of that revenue, giving Cliffs direct leverage to any sustained increase in flat-rolled steel pricing.
- Deep discount to historical multiples: The price-to-sales ratio of 0.351x is a fraction of the 2.82x seen in Q1 2022 and 2.02x in Q4 2023, while price-to-book of 1.069x is down from 2.65x in Q1 2022. If the recovery delivers even a portion of the forward EPS estimate of $0.894, the stock re-rating toward historical mid-cycle multiples implies substantial upside.
- Tariff protection supports pricing: Protective tariffs on imported steel have created a domestic pricing umbrella, and the August 21, 2026 news of potential tariff relief plus a $1 billion investment in Cliffs' flagship plant drove a 4.9% single-day gain. As the largest North American flat-rolled producer, Cliffs is structurally positioned to capture tariff-supported pricing.
Bearish
- Negative gross margin is unsustainable: Q1 2026 gross margin was -1.67% (gross profit of -$82 million), meaning Cliffs sold steel for less than the direct cost of producing it. The trailing gross margin of -4.10% and net margin of -7.94% confirm that current pricing does not cover full production costs, leaving the company dependent on external price support rather than internal economics.
- Cash burn and thin liquidity: Trailing free cash flow is -$997 million, with Q1 2026 free cash flow of -$477 million and operating cash flow of -$325 million. The cash position was just $45 million at quarter-end, and the company raised $951 million of common stock in Q4 2025 and took $454 million of net financing inflows in Q1 2026 — clear evidence that operations cannot self-fund.
- Stretched balance sheet with negative coverage: Debt-to-equity stands at 1.336 with total debt at 57.14% of capitalization, and interest expense of $148 million per quarter against negative operating income produces an interest coverage ratio of -1.40. ROE of -24.17% and ROA of -1.71% show that the capital structure is destroying value at the current earnings run-rate.
- Analyst consensus offers no upside: The average target price of $12.20 implies just +1.2% upside from the current $12.06, and the recommendation mean of 2.92 is essentially a pure hold. Morgan Stanley downgraded to Equal Weight on June 22, 2026, and most recent actions from Wells Fargo, BofA, Citigroup, and JP Morgan are neutral reiterations, signaling that the professional community sees no margin of safety.
CLF Technical Analysis
CLF is in a volatile, range-bound recovery phase rather than a clean trend: the shares are up 2.29% over the past year but down 11.32% year-to-date, and at $12.06 the stock sits at roughly 48.3% of its 52-week range (52-week low of $7.73, high of $16.70). That mid-range positioning reflects a market that has repeatedly repriced the name in both directions, with a punishing 51.67% max drawdown over the period underscoring how violently sentiment has swung. The 6-month gain of 42.55% versus the 1-year gain of just 2.29% tells the story of a sharp rally off the lows that has since stalled, leaving the stock neither a momentum leader nor a deep-value falling knife. Recent momentum has clearly decelerated: the 1-month change is -1.55% and the 3-month change is -12.48%, a marked deterioration from the strong 6-month print, while the 1-year figure remains marginally positive. This divergence between a strong 6-month trend and negative 1- and 3-month readings signals a maturing rally that has entered a corrective/consolidation phase, with the stock giving back a meaningful chunk of its spring gains even as it holds well above the 52-week low. Relative strength confirms the fade, with CLF trailing SPY by 15.52 percentage points over 3 months and 23.40 points year-to-date, though it still leads SPY by 27.15 points over 6 months, a classic pattern of a sharp spike followed by underperformance. Key levels are well defined: the $7.73 52-week low is the line in the sand for the recovery thesis, while the $16.70 high marks the resistance that would need to be reclaimed to confirm a new leg higher; a break below $7.73 would signal the tariff/recovery narrative is failing, whereas a move through $16.70 would validate the bull case. Volatility is a critical risk-management consideration, with a beta of 2.11 implying the stock is roughly 111% more volatile than the market, and a short ratio of 5.02 days indicating meaningful bearish positioning that could fuel sharp squeezes on positive catalysts but also amplifies downside on disappointments.
Beta
2.11
2.11x market volatility
Max Drawdown
-51.7%
Largest decline past year
52-Week Range
$8-$17
Price range past year
Annual Return
+9.4%
Cumulative gain past year
| Period | CLF Return | S&P 500 |
|---|---|---|
| 1m | +11.9% | -1.0% |
| 3m | +1.8% | +2.0% |
| 6m | +59.8% | +17.4% |
| 1y | +9.4% | +15.0% |
| ytd | -8.1% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CLF Fundamental Analysis
The revenue trajectory is stabilizing but not yet growing meaningfully: Q1 2026 revenue of $4.922 billion rose 6.33% year-over-year versus Q1 2025's $4.629 billion, and the sequential path from Q2 2025 ($4.934 billion), Q3 2025 ($4.734 billion), and Q4 2025 ($4.313 billion) into Q1 2026 shows a trough-and-rebound pattern rather than a durable uptrend. The Steelmaking segment dominates at $4.757 billion of the quarter's revenue versus just $165 million from Other Businesses, meaning the entire investment case hinges on flat-rolled steel pricing and automotive demand rather than diversification. The modest YoY growth is encouraging against a backdrop of tariff-supported domestic pricing, but with revenue still below the $5.092 billion posted in Q2 2024, the top line has not recovered to prior-cycle peaks, implying the recovery is real but shallow and highly dependent on external pricing support. Profitability remains the central problem: Q1 2026 net income was -$237 million on a gross margin of -1.67% (gross profit of -$82 million), and the trailing net margin of -7.94% with a gross margin of -4.10% confirms the company is still losing money at the operating level. The good news is the trend is improving — net income improved from -$495 million in Q1 2025 to -$237 million in Q1 2026, and gross margin recovered from -8.45% in Q1 2025 to -1.67% in Q1 2026, while EBITDA swung from -$208 million to +$100 million over the same span. Still, a negative gross margin is deeply unusual even for a cyclical steelmaker and signals that current pricing does not cover the full cost of production, leaving the company reliant on further price improvement or cost reduction to reach breakeven. The balance sheet is stretched and cash generation is negative: debt-to-equity stands at 1.336 with a total-debt-to-capitalization ratio of 57.14%, ROE is -24.17% and ROA is -1.71%, and trailing free cash flow is -$997 million against Q1 2026 free cash flow of -$477 million and operating cash flow of -$325 million. Liquidity is adequate on a current-ratio basis at 1.95, but the cash position is razor-thin at just $45 million at quarter-end, and the company funded itself with $454 million of net financing inflows in Q1 2026 after issuing $951 million of common stock in Q4 2025 — clear evidence that growth and operations are being funded externally rather than internally. With interest expense running at $148 million per quarter against negative operating income, the interest coverage ratio of -1.40 highlights genuine financial risk if the recovery stalls.
Quarterly Revenue
$4.9B
2026-03
Revenue YoY Growth
+6.3%
YoY Comparison
Gross Margin
-1.7%
Latest Quarter
Free Cash Flow
$-997000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CLF Overvalued?
Because Cleveland-Cliffs reported negative trailing net income (EPS of -$0.226 and trailing PE of -4.43x), the PE ratio is not meaningful, so the appropriate primary metric is the price-to-sales ratio of 0.351x, supplemented by the EV/Sales of 0.761x and the forward PE of 20.21x. The enormous gap between the meaningless trailing PE and the positive forward PE of 20.21x — built on consensus estimated EPS of $0.894 — tells the entire story: the market is pricing in a full earnings recovery, and the stock is only "cheap" if that recovery materializes. The forward PE of ~20x is not inexpensive for a cyclical steelmaker at the start of a recovery, implying investors are already paying up for the expected earnings rebound rather than getting it for free. On a peer basis, the 0.351x PS ratio and 1.069x price-to-book look optically cheap versus the broader Basic Materials sector, where profitable steel and materials names typically command PS multiples of 1.0x-2.0x and P/B above 1.5x, implying CLF trades at a substantial discount on sales and book value. However, that discount is justified by inferior profitability — a -7.94% net margin and -4.10% gross margin versus the positive margins typical of healthy steel peers — and by the negative $997 million trailing free cash flow, so the low PS is a reflection of impaired economics rather than a mispricing. The EV/EBITDA of -147.98x is negative and therefore meaningless, reinforcing that asset-based and sales-based metrics are the only valid lenses until EBITDA turns sustainably positive. Historically, CLF's own valuation band has compressed dramatically: PS was 2.82x in Q1 2022 and 2.02x in Q4 2023 versus 0.351x today, and P/B has fallen from 2.65x in Q1 2022 to 1.069x now, placing the stock near the bottom of its multi-year valuation range. That historical compression cuts both ways — it can signal a genuine value opportunity if the earnings recovery delivers, or it can reflect permanent fundamental deterioration in a business that has posted negative gross margins for multiple consecutive quarters; the forward PE of 20x suggests the market is already leaning toward the optimistic interpretation.
PE
-4.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-148.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute and quantifiable. The company reported a Q1 2026 gross margin of -1.67% (gross profit of -$82 million), meaning it is selling steel below the direct cost of production, and the trailing net margin of -7.94% confirms that no level of the current revenue base produces positive earnings. Free cash flow is deeply negative at -$997 million trailing and -$477 million in Q1 2026 alone, while the cash balance stood at just $45 million at quarter-end, leaving the company dependent on external financing — evidenced by $951 million of common stock issued in Q4 2025 and $454 million of net financing inflows in Q1 2026. With debt-to-equity at 1.336, interest expense of $148 million per quarter, and an interest coverage ratio of -1.40, a stall in the recovery would quickly escalate into a liquidity event or further shareholder dilution.
Market and competitive risks are amplified by the stock's extreme volatility and sector dynamics. The beta of 2.11 means CLF is roughly 111% more volatile than the market, so a 10% market decline could translate into a 20%+ drop in the shares, and the 51.67% max drawdown over the past year demonstrates this in practice. The stock trades at a forward PE of 20.21x, which is not cheap for a cyclical steelmaker at the start of a recovery, and the 0.351x PS ratio — while optically low versus the 1.0x-2.0x typical of profitable materials peers — is justified by inferior profitability. Competitive divergence is a real threat: recent news highlighted that Steel Dynamics spiked on record shipments and strong pricing while Cliffs "still struggles," suggesting that tariff protection benefits efficient producers more than high-fixed-cost integrated mills. Additionally, the $1 billion flagship plant investment and potential tariff relief that drove the August 21 pop are not yet reflected in earnings, and any policy reversal on tariffs would remove the pricing umbrella entirely.
In a worst-case scenario, steel prices fail to hold, the 2026 recovery guidance is missed, and the company is forced into another equity raise to fund negative free cash flow. The stock would likely retest its 52-week low of $7.73, which represents a -35.9% decline from the current $12.06, and the analyst low target of $10.00 implies -17.1% downside even in a less severe outcome. If the recovery narrative fully breaks and the stock revisits its 51.67% max drawdown magnitude from the recent high of $16.70, the downside could exceed 50% from current levels. The combination of a 5.02 short ratio and 2.11 beta means the decline would likely be fast and disorderly, with forced selling amplifying the move. An investor at today's price could realistically lose 35-50% in this adverse scenario, and the thin $45 million cash position means there is little buffer before solvency concerns become material.
FAQ
The most severe risk is financial: negative gross margin of -1.67% in Q1 2026, -$997 million trailing free cash flow, and just $45 million of cash at quarter-end mean the company depends on external financing, and another equity raise would dilute shareholders. The second risk is balance-sheet stress, with debt-to-equity of 1.336, interest expense of $148 million per quarter, and an interest coverage ratio of -1.40 that leaves no cushion if the recovery stalls. The third risk is market and competitive: a 2.11 beta makes the stock roughly twice as volatile as the market, and recent news highlighted that Steel Dynamics is thriving on record shipments while Cliffs "still struggles," suggesting tariff benefits accrue more to efficient producers. The fourth risk is policy: the August 21, 2026 rally was tied to potential tariff relief, and any reversal would remove the domestic pricing umbrella that supports the entire bull case. Ranked by severity, the financial and balance-sheet risks are most immediate, followed by policy and competitive risks.
The 12-month forecast has three scenarios: a base case with 50% probability targeting $11.00-$13.50, a bull case with 25% probability targeting $15.00-$16.70, and a bear case with 25% probability targeting $7.73-$10.00. The base case assumes steel prices remain tariff-supported but do not spike, revenue holds near $4.7-5.0 billion per quarter, and gross margins hover near breakeven, keeping the stock around the $12.20 analyst average target. The bull case requires gross margins to turn sustainably positive and management's doubled EBITDA guidance to be met, driving the stock toward the $15.00 analyst high and potentially the $16.70 52-week high. The bear case assumes a tariff reversal or earnings miss that forces another equity raise, pushing the stock back toward the $7.73 52-week low. The base case is most likely because the recovery is real but shallow, and the key assumption is that no additional large equity raise is required.
CLF is undervalued on sales and book value but fairly valued to slightly expensive on forward earnings. The price-to-sales ratio of 0.351x is far below the 2.82x seen in Q1 2022 and 2.02x in Q4 2023, and price-to-book of 1.069x is down from 2.65x in Q1 2022, placing the stock near the bottom of its multi-year range. However, the forward PE of 20.21x on estimated EPS of $0.894 is not cheap for a cyclical steelmaker at the start of a recovery, and the trailing PE of -4.43x is meaningless because the company is losing money. The low PS ratio is justified by a -7.94% net margin and -4.10% gross margin, which are far worse than profitable steel peers that typically command 1.0x-2.0x PS. The market is pricing in a full earnings recovery, so the stock is only undervalued if that recovery materializes — otherwise the discount reflects permanent fundamental impairment.
From a risk/reward perspective, CLF is a speculative buy only for investors who can tolerate high volatility and a multi-quarter waiting period. The analyst average target of $12.20 implies just +1.2% upside from the current $12.06, and the consensus rating is a hold with a 2.92 recommendation mean, so there is no margin of safety in the professional view. The biggest downside risk is a retest of the $7.73 52-week low, which would represent a -35.9% loss, and the company is burning cash with a -$997 million trailing free cash flow. However, the EBITDA swing from -$208 million to +$100 million and the 0.351x PS ratio mean that if the recovery delivers, the stock could reach the $15.00 analyst high target (+24%). It is a good buy for risk-tolerant investors who believe tariff-supported steel pricing will hold and who can withstand a 35%+ drawdown, but not for conservative portfolios.
CLF is better suited for short-to-medium-term tactical trading than long-term buy-and-hold investing, given its 2.11 beta, 51.67% max drawdown, and binary dependence on steel pricing and tariff policy. The company pays no dividend (dividend yield of 0%), has negative earnings visibility with a -7.94% net margin, and is still in the early stages of a turnaround, so there is no income or compounding argument for a long-term hold. Short-term traders can exploit the 5.02-day short ratio and 2.11 beta for catalyst-driven moves, such as the July 23 surge of +15.9% or the August 21 pop of +4.9%. For investors seeking long-term exposure, a minimum holding period of 2-3 years is required to give the 2026 recovery guidance time to translate into positive gross margins and free cash flow, but position sizing should be small given the 35-50% potential downside. A reasonable approach is to treat CLF as a satellite cyclical position rather than a core holding.